Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Zenabis Global Inc. T.ZENA

We are a diverse, passionate team of doctors, scientists, researchers, growers, educators, and advocates who came together with the goal of increasing access to safe, high quality cannabis for medical patients and recreational consumers. Our four facilities are located coast-to-coast across Canada in Delta and Langley, British Columbia; Atholville, New Brunswick; and Stellarton, Nova Scotia. Zenabis currently owns 3.5 million square feet of facility space.


TSX:ZENA - Post by User

Post by wanttoretireearlyon Feb 18, 2021 9:27am
103 Views
Post# 32594242

Globe says Hexo seen accelerating its profitability

Globe says Hexo seen accelerating its profitability

 

Globe says Hexo seen accelerating its profitability

 

2021-02-18 09:00 ET - In the News

See In the News (C-HEXO) Hexo Corp (2)

The Globe and Mail reports in its Thursday, Feb. 18, edition that CIBC World Markets analyst John Zamparo thinks Hexo's $235-million acquisition of Zenabis Global should "materially improve and accelerate" its profitability, prompting him to raise his rating to "outperformer" from "neutral." The Globe's David Leeder writes in the Eye On Equities column that Mr. Zamparo also elevated his share target to $13.50 from $5.60. Analysts on average target the shares at $5.05. Mr. Zamparo says in a note: "The most important part of this deal, as with any in the Canadian cannabis space in our view, is the synergies (estimated at $20-million; we forecast $15-million). Zenabis shares have struggled in the past, but this largely reflected balance sheet woes, which have been mostly addressed, and an all-stock deal to acquire a profitable player at four-times sales when HEXO trades at eight times provides meaningful value. With valuation in check versus peers (though we acknowledge the sector's well-above average valuations), moderate sales momentum, and the upcoming catalyst of positive EBITDA, we believe HEXO has upside." The Globe's guest columnist Michael Pe was bullish on Hexo on Jan. 19 when it could be had for $9.14.

<< Previous
Bullboard Posts
Next >>